logo

For the Inventor, By the Inventor

Winnipeg, Canada

Eva Anne Turley

This inventor holds 11 USPTO granted patents. Top assignees: Hyal Pharmaceutical Corporation, Jagotec Ag, Cangene Corporation. Active years: 1997-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eva Anne Turley. Retrieved from https://idiyas.com/inventor/eva-anne-turley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 11

% Patents Active = 90.9

Average Co-Inventor Count = 2.2

ph-index = 8

Forward Citations = 153(Granted Patents)


Location History:

  • Winnipeg, CA (1997 - 2005)
  • Toronto, CA (2001 - 2005)

Company Filing History:

goldMedal5 out of 41 
 
Hyal Pharmaceutical Corporation
 patents
silverMedal2 out of 70 
 
Jagotec Ag
 patents
bronzeMedal1 out of 13 
 
Cangene Corporation
 patents
4. 1 out of 1 
 
Meditech Research, Ltd.
 patent
5. 1 out of 7 
 
Transition Therapeutics, Inc.
 patents
6. 1 out of 834,601 
Other
 patents

Years Active: 1997-2005

Loading Chart...
11 patents (USPTO):Explore Patents
1. 6911429 - Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans (2005-06-28),
2. 6864235 - Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans (2005-03-08),
3. 6852708 - Use of hyaluronic acid and forms to prevent the narrowing of the vascular walls (2005-02-08),
4. 6537978 - Oral administration of effective amounts of forms of hyaluronic acid (2003-03-25),
5. 6475795 - Use of hyaluronan in gene therapy (2002-11-05),
6. 6271344 - Enhanced affinity hyaluronan binding peptides (2001-08-07),
7. 6022866 - Use of hyaluronic acid and forms to prevent arterial restenosis (2000-02-08),
8. 5990095 - Use of hyaluronic acid and forms to prevent arterial restenosis (1999-11-23),
9. 5834444 - Hyaluronic acid and salts thereof inhibit arterial restenosis (1998-11-10),
10. 5767106 - Treatment of disease and conditions associated with macrophage (1998-06-16),
11. 5614506 - Use of hyaluronic acid and forms to prevent arterial restenosis (1997-03-25),

Title: Innovations and Contributions of Eva Anne Turley

Introduction

Eva Anne Turley is a prominent inventor based in Winnipeg, Canada. She has made significant contributions to the field of biomedical research, particularly in the treatment of cellular responses to injury and proliferating cell disorders. With a total of 11 patents to her name, her work has the potential to impact various medical conditions.

Latest Patents

One of her latest patents focuses on compositions and methods for treating tissue disorders associated with a response-to-injury process or proliferating cells in mammals. This invention addresses tissue disorders such as fibrosis, inflammation, degeneration, and invasive disorders, including those related to cancerous cells. The methods involve administering an effective amount of a composition that alters the activity of transition molecules within a cell. These transition molecules include hyaladherins and hyaluronans, which play a crucial role in regulating the transitional phenotype of cells.

Career Highlights

Throughout her career, Eva has worked with notable companies such as Hyal Pharmaceutical Corporation and Jagotec AG. Her innovative research has led to advancements in understanding how to treat various tissue disorders effectively.

Collaborations

Eva has collaborated with esteemed colleagues, including Rudolf Edgar Falk and Samuel Simon Asculai, to further her research and develop her patented technologies.

Conclusion

Eva Anne Turley is a trailblazer in her field, with her inventions paving the way for new treatments in cellular response and tissue disorders. Her contributions continue to inspire advancements in biomedical research and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…